Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-22

Clinical Trial Update: YH1 in Poorly Controlled Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update for YH1 in poorly controlled Type 2 Diabetes has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YH1

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-07-22